Evolent Financial Statements From 2010 to 2025
| 9EH Stock | EUR 8.80 0.10 1.15% |
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
Evolent |
Evolent Health Company Current Valuation Analysis
Evolent Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Evolent Health Current Valuation | 3.01 B |
Most of Evolent Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolent Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Evolent Health has a Current Valuation of 3.01 B. This is 84.43% lower than that of the Technology sector and 22.6% higher than that of the Health Information Services industry. The current valuation for all Germany stocks is 81.91% higher than that of the company.
Evolent Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolent Health's current stock value. Our valuation model uses many indicators to compare Evolent Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolent Health competition to find correlations between indicators driving Evolent Health's intrinsic value. More Info.Evolent Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolent Health's earnings, one of the primary drivers of an investment's value.About Evolent Health Financial Statements
Evolent Health stakeholders use historical fundamental indicators, such as Evolent Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolent Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Evolent Health's assets and liabilities are reflected in the revenues and expenses on Evolent Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Evolent Health. Please read more on our technical analysis and fundamental analysis pages.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Evolent Stock
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out the analysis of Evolent Health Correlation against competitors. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.